An inhibitor of kynurenine 3-monooxygenase
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

GSK180

Item No. 19217

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
5,6-dichloro-2-oxo-3(2H)-benzoxazolepropanoic acid
CAS Number
1799725-26-0
Molecular Formula
C10H7Cl2NO4
Formula Weight
276.1
Purity
≥95%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥10 mg/ml
SMILES
O=C1N(CCC(O)=O)C2=CC(Cl)=C(Cl)C=C2O1
InChi Code
InChI=1S/C10H7Cl2NO4/c11-5-3-7-8(4-6(5)12)17-10(16)13(7)2-1-9(14)15/h3-4H,1-2H2,(H,14,15)
InChi Key
MIGAKMWKMLYGJX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $39

    Add

    5 mg

    $164

    Add

    10 mg

    $270

    Add

    25 mg

    $482

    Add
    Product Description

    GSK180 is an inhibitor of kynurenine 3-monooxygenase (IC50 = 6.3 nM).1 It is selective for human over P. fluorescens kynurenine 3-monooxygenase (IC50 = 500 nM). GSK180 (27 mg/kg) increases circulating levels of kynurenine and kynurenic acid in mice.2 It protects against secondary acute lung injury and renal injury in a rat model of experimentally induced acute pancreatitis multiple organ dysfunction syndrome (AP-MODS).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Liddle, J., Beaufils, B., Binnie, M., et al. The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis. Bioorg. Med. Chem. Lett. 27(9), 2023-2028 (2017).

    2. Mole, D.J., Webster, S.P., Uings, I., et al. Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis. Nat. Med. 22(2), 202-209 (2016).